INJ Price Prediction: Targets $3.44-$3.60 Recovery as Technical Bounce Expected
Injective (INJ) trades at $3.00 with oversold RSI at 39.66 suggesting potential bounce to $3.44-$3.60 resistance levels within 2-3 weeks...
INJ PRICE ANALYSIS
INJ Price Prediction: Targets $3.50-$4.00 by March Amid Technical Recovery Signals
Injective (INJ) shows bullish momentum at $3.41 with neutral RSI and key resistance breaks. Analysts target $3.50-$4.00 range within 4-6...
INJ Price Prediction: Targeting $4.50 Recovery by March Amid Oversold Conditions
Injective (INJ) trades at $3.06 with RSI at 28.83 showing oversold conditions. Technical analysis suggests potential bounce toward $4.50 resistance...
INJ Price Prediction: Injective Targets $5.80-$6.20 by February 2026
INJ Price Prediction Summary • Short-term target (1 week) : $4.72-$4.90 • Medium-term forecast (1 month) : $5.80-$6.20 range •...
INJ Price Prediction: Targets $6.20 by February as Bulls Eye Key Breakout
INJ Price Prediction Summary • Short-term target (1 week): $5.90 • Medium-term forecast (1 month): $6.00-$6.20 range • Bullish breakout...
INJ Price Prediction: Targets $6.20 by February as Technical Momentum Builds
Injective Protocol (INJ) has captured analyst attention as it trades at $5.37 following a strong 5.4% rally today. With technical...
Injective (INJ): EVM Testnet Launch, Strategic Partnerships, and Bullish Momentum in 2025
Injective (INJ) gains momentum with its EVM testnet launch, strategic partnerships with Google Cloud and Deutsche Telekom, and bullish price...
Injective (INJ) Rallies 15%: EVM Testnet Launch and Strategic Partnerships Drive Growth
Injective (INJ) surged 15% this week, fueled by its EVM testnet launch, strategic partnerships with Google Cloud and Deutsche Telekom,...
Injective (INJ) Surges 15% Amid EVM Testnet Launch and Strategic Partnerships
Injective (INJ) gains momentum with a 15% price surge, driven by its EVM testnet launch, soaring on-chain activity, and strategic...
Injective (INJ) Surges 15% Amid EVM Testnet Launch and Bullish Breakout
Injective (INJ) surged 15% this week, breaking a multi-month bearish trend. With its EVM testnet launch, rising adoption, and bullish...
